Skip to main content
NGL Fine Chem Ltd. logo

NGL Fine Chem Ltd. — Investor Relations & Filings

Ticker · NGLFINE ISIN · INE887E01022 LEI · 335800X5TUU2OAV19X07 BSE.NS Manufacturing
Filings indexed 308 across all filing types
Latest filing 2026-02-03 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS NGLFINE

About NGL Fine Chem Ltd.

https://www.nglfinechem.com

NGL Fine Chem Ltd. specializes in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and intermediates for both veterinary and human healthcare sectors. The company focuses on high-quality chemical synthesis, producing a diverse range of products including anthelmintics, ectoparasiticides, and specialty chemicals. Key products in its portfolio include Nitroxynil, Closantel, Oxyclozanide, and Triclabendazole. Operating with Good Manufacturing Practice (GMP) standards, the firm serves a global clientele, providing customized manufacturing solutions and maintaining a strong emphasis on research and development to enhance process efficiency and product quality. Its technical expertise lies in complex chemical reactions and large-scale production of niche pharmaceutical components.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Interim / Quarterly Report Classification · 92% confidence The document is a filing to stock exchanges under SEBI Listing Regulations (“Outcome of the Board Meeting”) that includes the Board‐approved unaudited financial results (quarter and nine months ended December 31, 2025) together with the independent auditor’s limited review report. It contains full interim financial statements (consolidated and standalone) and notes, not merely an announcement that a report is attached. Therefore, it is a substantive interim/quarterly financial report. 9M 2025
2026-02-03 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 90% confidence The document is the outcome of a board meeting under SEBI LODR Regulations approving unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, and includes the Independent Auditor’s Limited Review Report and detailed financial tables. It contains actual interim financial statements, not merely an announcement of publication. Therefore it is classified as an Interim / Quarterly Report. 9M 2025
2026-02-03 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2026-01-12 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notice informing the stock exchanges about the upcoming Fourth Board Meeting of the financial year 2025-26. The purpose of the meeting is to approve unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The document is a formal announcement of a board meeting date and agenda, not the financial results report itself. It is short (1628 characters) and serves as a notification to the exchanges, consistent with a Regulatory Filing (RNS) rather than an Interim/Quarterly Report (IR) or Earnings Release (ER).
2026-01-12 English
Resignation
Board/Management Information Classification · 95% confidence The document is an intimation to stock exchanges regarding the resignation of the Company Secretary & Compliance Officer, which is a change in key senior management. It references SEBI Listing Obligations Regulation 30 and provides details on the cessation of a Key Managerial Personnel. This fits Squarely under Board/Management Information (MANG), which covers announcements of changes in the company’s board or senior management.
2026-01-05 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Major Shareholding Notification Classification · 90% confidence The document consists primarily of a tabular listing of shareholder names, certificate numbers, share quantities, and dematerialization dates. There is no narrative text, financial data, management discussion, or regulatory references. The content appears to be a record of share certificates and shareholder details, which aligns with notifications about share ownership or share certificates. It does not contain any financial report, meeting materials, voting results, or legal proceedings. Given the nature of the data, it most closely fits the category of Major Shareholding Notification (MRQ), which involves notifications of changes or details in significant share ownership levels. The document is short and factual, not an announcement of a report or a certification letter, so it is not RPA or RNS. Therefore, the best classification is MRQ with high confidence.
2026-01-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.